New adamantan-2-ol and adamantan-1-methanol derivatives as potent antibacterials. Synthesis, antibacterial activity and lipophilicity studies

被引:29
作者
AntoniadouVyza, E [1 ]
Tsitsa, P [1 ]
Hytiroglou, E [1 ]
TsantiliKakoulidou, A [1 ]
机构
[1] UNIV ATHENS,FAC MED,DEPT MICROBIOL,GR-11527 ATHENS,GREECE
关键词
adamantane; charged nitrogen; antibacterial agent; lipophilicity;
D O I
10.1016/0223-5234(96)80443-0
中图分类号
R914 [药物化学];
学科分类号
100701 [药物化学];
摘要
Two series of active adamantane-group-bearing trialkylamines and their quaternary ammonium salts were synthesized and their biological properties were tested. One series includes 2-(3-dialkylaminopropyl)tricyclo[3.3.1.1(3,7)] decan-2-ols and the other alpha,alpha-bis(3-dialkylaminopropyl)tricyclo[3.3.1.1(3,7)]decyl/1-methanols. Some of the synthesized molecules proved to be very active anti bacterials. The minimum inhibitory concentration (MIG) values of the most potent compounds were determined. The observed differences were investigated. The antibacterial activity of the compounds was found to be enhanced as the length of the nitrogen-attached carbon chain extends from CH3 to C12H25. The lipophilicity of the synthesized molecules was also studied and its relationship with the antibacterial activity was investigated.
引用
收藏
页码:105 / 110
页数:6
相关论文
共 12 条
[1]
ANTONIADOUVYZAS A, 1986, EUR J MED CHEM, V21, P73
[2]
GAROUFALIAS S, 1988, Annales Pharmaceutiques Francaises, V46, P97
[3]
GILMAN AG, 1992, PHARMACOL BASIS THER, V2, P978
[4]
COMPARATIVE SUSCEPTIBILITY OF HOSPITAL ISOLATES OF GRAM-NEGATIVE BACTERIA TO ANTISEPTICS AND DISINFECTANTS [J].
HAMMOND, SA ;
MORGAN, JR ;
RUSSELL, AD .
JOURNAL OF HOSPITAL INFECTION, 1987, 9 (03) :255-264
[5]
LIPOPHILIC CHARACTER AND BIOLOGICAL-ACTIVITY OF DRUGS .2. PARABOLIC CASE [J].
HANSCH, C ;
CLAYTON, JM .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1973, 62 (01) :1-21
[6]
Hansch C., 1979, SUBSTITUENT CONSTANT, P18
[7]
Harms A., 1975, DRUG DESIGN, V6, P1
[8]
Lien E.J., 1975, Drug design: Medicinal chemistry: A series of monographs, VV, P81
[9]
ROSSEELS G, 1970, SYNTHESIS-STUTTGART, P302
[10]
ROVATI L, 1984, DRUG FUTURE, V9, P167